Request for Covid-19 Impact Assessment of this Report
Market Dynamics
The rapidly growing pharmaceutical R&D investments along with the availability of public and private funding for life science research studies are the prime drivers for the life science & chemical instrumentation market. Moreover, a rise in the incidences of chronic diseases and growing food safety concerns has led to the increased importance of this market. Apart from these factors increasing demand for analytical instruments from applied markets act as growth drivers
The high cost of developing and marketing such instruments, scarcity of skilled professionals, and presence of alternative analytical technologies put constraints on the market.
Market Segmentation
The market is segmented in by type of technology (chromatography, electrophoresis, DNA sequencers and amplifiers, lab automation, spectroscopy, immunoassay, microarray, flow cytometry, and other instruments), by end users (pharmaceutical, biopharmaceutical, and biotechnology companies; clinical research organizations (CROs), research institutions; hospitals, clinics, and diagnostic laboratories; academic institutions; forensic science laboratories; food and agriculture industry; and environmental testing industry), by region (North America, Asia-Pacific, Europe and the rest of world).
Geographic Analysis
North America leads the life science & chemical instrumentation market followed by Europe. However, Asia-Pacific is expected to grow rapidly due to increasing outsourcing activities in life science sector, in this manner leading to growth in demand for life science and chemical instruments.
Key Players
Some of the major players in the market include Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Bruker Corporation, PerkinElmer, Inc., and Waters Corporation.
The report contains comprehensive analysis on:
--> Life Science & Chemical Instrumentation Market Segments
--> Life Science & Chemical Instrumentation Market Drivers, Restraints and Opportunities
--> Life Science & Chemical Instrumentation Market Size & Forecast 2016 to 2022
--> Supply & Demand Value Chain
--> Life Science & Chemical Instrumentation Market Current Trends
--> Competition & Major Companies
--> Technology and R&D Status
--> Porters Five Force Analysis
--> Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Life Science & Chemical Instrumentation Market includes
--> North America
>> US and Canada
--> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
--> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
--> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
--> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
--> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.
Report Highlights::
--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
--> Consumer and Pricing Analysis
--> Market dynamics of the industry
--> In-depth Market Segmentation
--> Historical and Projected Market Sizing in terms of volume and value
--> Recent market trends and Impact Factors
--> R&D Status and Technology Overview
--> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...